|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.00 EUR | -0.36% |
|
+3.93% | +9.98% |
| 23/06 | Orion's Investigational Drug Wins EU Orphan Drug Designation to Treat Malignant Mesothelioma | MT |
| 16/06 | Digia Unit to Provide Data Integration, AI Analytics for Finnish Health Sector Project | MT |
| Market Cap | 9.87B 11.25B 9.1B 8.51B 15.97B 1,062B 16.3B 109B 42.3B 525B 42.26B 41.33B 1,819B | P/E 2026 * |
17.9x | P/E 2027 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise Value | 9.77B 11.14B 9B 8.43B 15.8B 1,051B 16.13B 108B 41.87B 519B 41.83B 40.91B 1,801B | EV / Sales 2026 * |
4.69x | EV / Sales 2027 * | 4.06x |
| Free-Float |
90.5% | Yield 2026 * |
2.72% | Yield 2027 * | 3.02% |
Last Transcript: Orion Oyj
| 1 day | -0.36% | ||
| 1 week | +3.93% | ||
| Current month | -2.23% | ||
| 1 month | -1.41% | ||
| 3 months | +4.63% | ||
| 6 months | +10.15% | ||
| Current year | +9.98% |
| 1 week | 66.85 |  | 70.8 |
| 1 month | 66.1 | | 71.65 |
| Current year | 62.7 | | 75.3 |
| 1 year | 56.5 | | 75.3 |
| 3 years | 31.86 | | 75.3 |
| 5 years | 31.86 | | 75.3 |
| 10 years | 22.57 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/11/2022 | |
René Lindell
DFI | Director of Finance/CFO | 50 | 01/05/2024 |
| Chief Operating Officer | 46 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 22/03/2017 | |
Hilpi Rautelin
BRD | Director/Board Member | 65 | 22/03/2017 |
Kari Jussi Aho
BRD | Director/Board Member | 66 | 06/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/08/25 | Sell | Chief Operating Officer | 4,000 | 0.0122% | ||
| 04/08/25 | Sell | Executive/Senior Manager | 724 | 0.0022% | ||
| 04/08/25 | Sell | Executive/Senior Manager | 1,600 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | +3.93% | +11.91% | +85.28% | 11.26B | |
| +7.13% | +9.97% | +51.94% | +166.83% | 1,006B | |
| +3.99% | +11.50% | +67.53% | +55.63% | 589B | |
| +4.20% | +17.03% | +35.63% | +87.74% | 430B | |
| +0.99% | +4.85% | +27.93% | +22.82% | 331B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | |
| +1.56% | +6.14% | +28.38% | +59.45% | 190B | |
| +3.26% | +3.33% | +18.83% | +67.03% | 154B | |
| Average | +1.82% | +8.05% | +28.86% | +57.28% | 349.7B | |
| Weighted average by Cap. | +2.24% | +9.13% | +40.11% | +79.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.08B 2.37B 1.92B 1.8B 3.37B 224B 3.44B 23.05B 8.92B 111B 8.91B 8.72B 384B | 2.35B 2.68B 2.17B 2.03B 3.81B 253B 3.88B 26.05B 10.08B 125B 10.07B 9.85B 434B |
| Net income | 550M 627M 507M 474M 889M 59.12B 908M 6.09B 2.36B 29.22B 2.35B 2.3B 101B | 649M 740M 598M 560M 1.05B 69.84B 1.07B 7.19B 2.78B 34.52B 2.78B 2.72B 120B |
| Net Debt | -101M -115M -92.78M -86.86M -163M -10.83B -166M -1.12B -431M -5.35B -431M -422M -18.56B | -313M -357M -288M -270M -506M -33.65B -517M -3.46B -1.34B -16.63B -1.34B -1.31B -57.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | EUR 70.00 | -0.36% | 126,648 |
| 25/06/26 | EUR 70.25 | +1.01% | 155,240 |
| 24/06/26 | EUR 69.55 | +0.94% | 162,797 |
| 23/06/26 | EUR 68.90 | +0.58% | 200,531 |
| 22/06/26 | EUR 68.50 | +1.71% | 372,530 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORNBV Stock
Select your edition
All financial news and data tailored to specific country editions
